RGEN
NASDAQ · Life Sciences Tools & Services
Repligen Corp
$173.49
+5.01 (+2.97%)
Performance
1D
+0.00%
1W
+0.31%
1M
+5.89%
3M
+6.32%
6M
+49.68%
1Y
+21.47%
YTD
+5.56%
Open$169.35
Previous Close$168.48
Day High$175.00
Day Low$168.05
52W High$198.87
52W Low$100.99
Volume—
Avg Volume1.62M
Market Cap11.00B
P/E Ratio—
EPS$-0.21
SectorLife Sciences Tools & Services
Technical Indicators
Full analysis →
SMA 50
$177.35
Below
SMA 200
$144.99
Above
RSI (14)
47.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-64.2% upside
Current
$173.49
$173.49
Target
$62.10
$62.10
$40.44
$62.10 avg
$74.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 827.34M | 850.29M | 4.59B |
| Net Income | 54.79M | 50.68M | 325.04M |
| Profit Margin | 6.6% | 6.3% | 7.1% |
| EBITDA | 150.07M | 146.52M | 499.02M |
| Free Cash Flow | — | — | 285.62M |
| Rev Growth | -2.7% | -2.7% | +1.3% |
| Debt/Equity | 0.26 | 0.26 | 0.50 |
Life Sciences Tools & Services Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc | $694.76 | +2.63% | 36.1 | 255.13B |
| DHR | Danaher Corp | $230.25 | +1.73% | 36.9 | 159.65B |
| A | Agilent Technologies Inc | $174.76 | +1.73% | 33.6 | 48.43B |
| IQV | Iqvia Holdings Inc | $271.83 | +2.62% | 32.2 | 44.90B |
| MTD | Mettler-Toledo International | $1,722.15 | +2.57% | 38.5 | 34.87B |
| WAT | Waters Corp | $457.60 | +1.00% | 260.1 | 43.22B |